Sign In
Buy EVOK
$11.00
+0 (+0%)
At Close: Mar 16, 2026
Agios Pharmaceuticals (NASDAQ:AGIO) vs. Evoke Pharma (NASDAQ:EVOK) Head-To-Head Comparison
07:22am, Sunday, 12'th Apr 2020
Agios Pharmaceuticals (NASDAQ:AGIO) and Evoke Pharma (NASDAQ:EVOK) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their prof
Evoke Pharma (EVOK) Receives a Hold from H.C. Wainwright
11:13am, Monday, 23'rd Mar 2020
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Hold rating on Evoke Pharma (EVOK). The company's shares closed last Monday at
Evoke Pharma (EVOK) Receives a Hold from H.C. Wainwright
11:13am, Monday, 23'rd Mar 2020
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Hold rating on Evoke Pharma (EVOK – Research
Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results
12:30pm, Thursday, 12'th Mar 2020
SOLANA BEACH, Calif., March 12, 2020 -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today.
High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes?
12:00am, Tuesday, 10'th Mar 2020
By Double Blind's Madison Margolin, provided exclusively to Benzinga Cannabis.
The cannabis industry has drifted from its grassroots values. Will the psychedelic field learn...
Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™
01:30pm, Monday, 27'th Jan 2020
Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the United States Patent and Trademark Office (USPTO) issue
Evoke Pharma Receives Notice Of Allowance From USPTO For Gimoti
12:00am, Monday, 27'th Jan 2020Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™
01:30pm, Thursday, 23'rd Jan 2020
EVERSANA to commercialize and distribute Gimoti in the U.S. SOLANA BEACH, Calif. and CHICAGO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused
Evoke Pharma And Novos Growth Partners Mutually Agreed To Terminate Commercialization Agreement Dated Jan. 5, 2019
12:00am, Thursday, 23'rd Jan 2020Evoke Pharma's NDA Resubmission for Gimoti Gets FDA Acceptance
03:00pm, Wednesday, 22'nd Jan 2020
The FDA receives Evoke Pharma's (EVOK) refiling of new drug application for its pipeline candidate Gimoti, which is being developed to treat diabetic gastroparesis.
Evoke Pharma's NDA Resubmission for Gimoti Gets FDA Acceptance
03:00pm, Wednesday, 22'nd Jan 2020
The FDA receives Evoke Pharma's (EVOK) refiling of new drug application for its pipeline candidate Gimoti, which is being developed to treat diabetic gastroparesis.
18 Drug Manufacturers—Specialty & Generic Stocks Moving In Wednesday's Session
12:00am, Wednesday, 22'nd Jan 2020FDA Accepts Evoke Pharma’s NDA Resubmission for Gimoti™
01:30pm, Tuesday, 21'st Jan 2020
Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal (GI) disorders and diseases, today announced that the U.S. Food and Drug Adm
